Improvement of the oral praziquantel anthelmintic effect by cyclodextrin complexation
Contribuinte(s) |
Universidade Estadual Paulista (UNESP) |
---|---|
Data(s) |
20/05/2014
25/10/2016
20/05/2014
25/10/2016
01/01/2010
|
Resumo |
Schistosomiasis is a parasitic disease which kills a half million people per year, a I I over the world. Praziquantel (PZQ) is the drug-of-choice for schistosomiasis because of its effectiveness, ease of administration, and low cost. However, poor solubility restricts its delivery, especially via the oral route. In this study, we describe beta-cyclodextrin (beta-CD) complexation as an alternative to improve the PZQ bioavailability. Physicochemical analysis were performed to characterize the inclusion complex formed between PZQ and beta-CD. Differential scanning calorimetry (DSC) thermograms and morphological analysis using scanning electronic microscopy (SEM) gave evidences of the complex formation. Diffusion NMR experiments allowed determination of the fraction of PZQ bound to beta-CD (37%) and the association constant (941 +/- 47 M(-1)). The in vivo evaluation of the complexation on the effect of PZQ was performed on mice infected with Schistosoma mansoni (BH strain); after 15 days of treatment with the PZQ:beta-CD complex the efficacy, evaluated by the number of remaining alive worms, was 99%, against 59% elicited by plain PZQ. Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) |
Identificador |
Journal of Drug Targeting. Abingdon: Taylor & Francis Ltd, v. 18, n. 1, p. 21-26, 2010. 1061-186X http://hdl.handle.net/11449/183 http://acervodigital.unesp.br/handle/11449/183 10.3109/10611860903131677 WOS:000274222800003 |
Idioma(s) |
eng |
Publicador |
Taylor & Francis Ltd |
Relação |
Journal of Drug Targeting |
Direitos |
info:eu-repo/semantics/closedAccess |
Palavras-Chave | #Praziquantel #cyclodextrin #inclusion complex #schistosomiasis |
Tipo |
outro |